|
Drugs:
Next outsourcing frontier for India
Hyderabad: the US pharmaceutical and biotechnology
industry finds big scope for partnering with the Indian
industry and outsourcing the R&D and clinical trial
services of drugs, in the face of prohibitive costs being
faced by drug companies around he world. With costs of
development globally, verging prohibitively at over $800
million for each new drug, and with an emerging opportunity
of over $53 billion in drugs going off-patent in the next
five-six years, the Indian biotechnology industry could
outsource in the areas of chemistry, biogenerics and clinical
trials.
At the global bio business forum - BioAsia — being
conducted at Hyderabad it emerged that the cost of clinical
trials in the US was estimated at around $150 million
per drug, which could be reduced by up to 60 per cent
through cooperation with the Indian companies. However,
the intellectual property (IP) protection and data efficacy
protection were the key areas of concern for the global
companies, that needed to be immediately addressed by
India.
Back
to News Review index page
Wipro
opts for Embarcadero tool
Bangalore: Wipro Technologies and the US-based
Embarcadero Technologies, have announced that Wipro's
Interops Solution Group has chosen Embarcadero Extreme
Test as a preferred application and performance testing
solution for its application development projects.
The Embarcadero Extreme Test will feature at Wipro's Centre
of Excellence in Bangalore, along with other Embarcadero
data lifecycle management tools for the benefit of prospective
customers.
Back
to News Review index page
WTO
chief to US: Outsourcing threat overblown
Washington: The director-general of the World Trade
Organization, Supachai Panitchpakdi has said that American
worries about the outsourcing of jobs were overblown.
He said that in actuality the US will create an average
of more than 2 million new services jobs a year over the
next decade, nearly ten the time the number that it expected
to lose through outsourcing. Supachai said that multilateral
free-trade deals, such as the one being proposed in the
WTO's Doha Round talks were the key to U.S. economic prosperity
and global growth
Back
to News Review index page
|
